FDA Inspection 859170 — Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC — FEI 1000115163

The FDA completed an inspection of Fresenius Kabi USA, LLC on December 17, 2013 in Melrose Park, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 17, 2013
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Melrose Park, IL (United States)